Amgen Inc. (LON:0R0T)

United States Steel Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 120.48 billion. The enterprise value is 157.15 billion.

Market Cap	120.48B
Enterprise Value	157.15B

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	537.71M
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.32M

Valuation Ratios

The trailing PE ratio is 26.24 and the forward PE ratio is 14.33.

PE Ratio	26.24
Forward PE	14.33
PS Ratio	4.56
PB Ratio	25.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.06, with an EV/FCF ratio of 18.60.

EV / Earnings	34.22
EV / Sales	6.10
EV / EBITDA	13.06
EV / EBIT	20.28
EV / FCF	18.60

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio	1.17
Quick Ratio	0.74
Debt / Equity	9.24
Debt / EBITDA	3.60
Debt / FCF	5.26
Interest Coverage	2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	105.67%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	9.67%
Return on Capital Employed (ROCE)	15.47%
Revenue Per Employee	943,328
Profits Per Employee	164,003
Employee Count	28,000
Asset Turnover	0.37
Inventory Turnover	1.37

Taxes

In the past 12 months, Amgen has paid 554.95 million in taxes.

Income Tax	554.95M
Effective Tax Rate	10.78%

Stock Price Statistics

The stock price has decreased by -11.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.98%
50-Day Moving Average	291.43
200-Day Moving Average	291.28
Relative Strength Index (RSI)	50.34
Average Volume (20 Days)	528

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.61

Income Statement

In the last 12 months, Amgen had revenue of GBP 26.41 billion and earned 4.59 billion in profits. Earnings per share was 8.47.

Revenue	26.41B
Gross Profit	18.24B
Operating Income	7.95B
Pretax Income	5.15B
Net Income	4.59B
EBITDA	12.17B
EBIT	7.95B
Earnings Per Share (EPS)	8.47

Balance Sheet

The company has 6.82 billion in cash and 44.41 billion in debt, giving a net cash position of -37.59 billion.

Cash & Cash Equivalents	6.82B
Total Debt	44.41B
Net Cash	-37.59B
Net Cash Per Share	n/a
Equity (Book Value)	4.80B
Book Value Per Share	8.93
Working Capital	3.03B

Cash Flow

In the last 12 months, operating cash flow was 9.44 billion and capital expenditures -988.39 million, giving a free cash flow of 8.45 billion.

Operating Cash Flow	9.44B
Capital Expenditures	-988.39M
Free Cash Flow	8.45B
FCF Per Share	n/a

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin	69.07%
Operating Margin	30.08%
Pretax Margin	19.49%
Profit Margin	17.39%
EBITDA Margin	46.08%
EBIT Margin	30.08%
FCF Margin	31.98%

Dividends & Yields

This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 2.44%.

Dividend Per Share	7.21
Dividend Yield	2.44%
Dividend Growth (YoY)	3.67%
Years of Dividend Growth	6
Payout Ratio	82.64%
Buyback Yield	-0.88%
Shareholder Yield	1.56%
Earnings Yield	3.81%
FCF Yield	7.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	6